A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

BACKGROUND: This multicentre randomised phase III trial was designed to determine whether adjuvant chemotherapy with gemcitabine improves the outcomes of patients with resected pancreatic cancer. METHODS: Eligibility criteria included macroscopically curative resection of invasive ductal carcinoma o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, H, Kosuge, T, Matsuyama, Y, Yamamoto, J, Nakao, A, Egawa, S, Doi, R, Monden, M, Hatori, T, Tanaka, M, Shimada, M, Kanemitsu, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743365/
https://www.ncbi.nlm.nih.gov/pubmed/19690548
http://dx.doi.org/10.1038/sj.bjc.6605256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743365/
https://www.ncbi.nlm.nih.gov/pubmed/19690548
http://dx.doi.org/10.1038/sj.bjc.6605256

Ejemplares similares